Publicacións (26) Publicacións de David García Solís

2024

  1. Correlation Between Amyloid PET Imaging and Discordant Cerebrospinal Fluid Biomarkers Results in Patients with Suspected Alzheimer's Disease

    Journal of Alzheimer's Disease, Vol. 97, Núm. 1, pp. 447-458

2023

  1. 18F-FDG PET for the diagnosis and assessment of treatment response of autoimmune limbic encephalitis

    Revista Espanola de Medicina Nuclear e Imagen Molecular, Vol. 42, Núm. 3, pp. 196-197

  2. Peripheral Inflammation Is Associated with Dopaminergic Degeneration in Parkinson's Disease

    Movement Disorders, Vol. 38, Núm. 5, pp. 755-763

2021

  1. Levodopa-Induced Dyskinesia in Parkinson Disease Specifically Associates with Dopaminergic Depletion in Sensorimotor-Related Functional Subregions of the Striatum

    Clinical Nuclear Medicine, Vol. 46, Núm. 6, pp. E296-E306

  2. TMA-93 Validation by Alzheimer's Disease Biomarkers: A Comparison with the Free and Cued Selective Reminding Test on a Biobank Sample

    Journal of Alzheimer's Disease, Vol. 82, Núm. 1, pp. 401-410

2020

  1. Differential diagnosis of HaNDL syndrome in a case report of a pediatric patient: The role of SPECT with 99mTc-HMPAO

    eNeurologicalSci, Vol. 19

2018

  1. A new stage in the diagnosis of Alzheimer's Disease

    Revista Espanola de Medicina Nuclear e Imagen Molecular

  2. Amyloid PET in neurodegenerative diseases with dementia

    Revista Espanola de Medicina Nuclear e Imagen Molecular, Vol. 37, Núm. 6, pp. 397-406

2017

  1. A Bayesian spatial model for neuroimaging data based on biologically informed basis functions

    NeuroImage, Vol. 161, pp. 134-148

  2. Genetic factors influencing frontostriatal dysfunction and the development of dementia in Parkinson's disease

    PLoS ONE, Vol. 12, Núm. 4

  3. Lower levels of uric acid and striatal dopamine in non-tremor dominant Parkinson's disease subtype

    PLoS ONE, Vol. 12, Núm. 3

  4. Nuevos tiempos para la neuroimagen de Medicina Nuclear en España: ¿de dónde partimos?

    Revista Espanola de Medicina Nuclear e Imagen Molecular, Vol. 36, Núm. 4, pp. 219-226

2016

  1. Cerebral and blood correlates of reduced functional connectivity in mild cognitive impairment

    Brain Structure and Function, Vol. 221, Núm. 1, pp. 631-645

2015

  1. Machine learning models for the differential diagnosis of vascular parkinsonism and Parkinson’s disease using [123I]FP-CIT SPECT

    European Journal of Nuclear Medicine and Molecular Imaging, Vol. 42, Núm. 1, pp. 112-119

2014

  1. Neuroimagen funcional en el diagnóstico de pacientes con síndrome parkinsoniano: Actualización y recomendaciones para el uso clínico

    Revista Espanola de Medicina Nuclear e Imagen Molecular, Vol. 33, Núm. 4, pp. 215-226

  2. SPECT / CT with 99mTc-HMPAO in progressive encephalitis mediated anti-GAD

    Revista de Neurologia

  3. Utilidad de la tomografía de emisión de fotón único-tomografía computarizada en la biopsia selectiva del ganglio centinela en pacientes con melanoma

    Revista Espanola de Medicina Nuclear e Imagen Molecular, Vol. 33, Núm. 3, pp. 129-135

  4. Utility of neuropsychiatric tools in the differential diagnosis of dementia with Lewy bodies and Alzheimer's disease: Quantitative and qualitative findings

    International Psychogeriatrics, Vol. 26, Núm. 3, pp. 453-461

2013

  1. Clinical features and 123I-FP-CIT SPECT imaging in vascular parkinsonism and Parkinson's disease

    Journal of Neurology, Neurosurgery and Psychiatry, Vol. 84, Núm. 2, pp. 122-129

  2. Elaboración de una plantilla de SPM para la normalización de imágenes de SPECT con 123I-Ioflupano

    Revista Espanola de Medicina Nuclear e Imagen Molecular, Vol. 32, Núm. 6, pp. 350-356